206650.KQ

EuBiologics Co., Ltd. [206650.KQ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

206650.KQ Stock Summary

Top 10 Correlated ETFs

206650.KQ


Top 10 Correlated Stocks

206650.KQ


In the News

206650.KQ Financial details

Company Rating
Neutral
Market Cap
442.54B
Income
-13.88B
Revenue
69.37B
Book val./share
3055.1
Cash/share
308.73
Dividend
-
Dividend %
-
Employees
323
Optionable
No
Shortable
Yes
Earnings
09 Feb 2021
P/E
-89.44
Forward P/E
9.71
PEG
-0.77
P/S
6.51
P/B
3.15
P/C
39.26
P/FCF
31.29
Quick Ratio
0.41
Current Ratio
1.43
Debt / Equity
0.12
LT Debt / Equity
0.03
-
-
EPS (TTM)
-380.72
EPS next Y
1248
EPS next Q
-
EPS this Y
1161.31%
EPS next Y
-427.8%
EPS next 5Y
-427.8%
EPS last 5Y
63.74%
Revenue last 5Y
15.97%
Revenue Q/Q
135.23%
EPS Q/Q
309.67%
-
-
-
-
SMA20
2.75%
SMA50
16.25%
SMA100
28.13%
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-3%
ROC
-0.03%
Gross Margin
42%
Oper. Margin
-8%
Profit Margin
-7%
Payout
-
Shs Outstand
36.45M
Shs Float
25.59M
-
-
-
-
Target Price
-
52W Range
6260.0-13500.0
52W High
-10.22%
52W Low
+93.61%
RSI
49
Rel Volume
0.41
Avg Volume
324.08K
Volume
134.3K
Perf Week
-0.08%
Perf Month
-1.86%
Perf Quarter
17.1%
Perf Half Y
17.21%
-
-
-
-
Beta
1.273
-
-
Volatility
287.97%, 350.04%
Prev Close
-0.08%
Price
12120
Change
-1.46%

206650.KQ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.21K1.02K1.11K1.52K1.9K
Net income per share
-32.35-2.15K-777.82-30.19-380.79
Operating cash flow per share
472.55-32.61-214.44176.92725.75
Free cash flow per share
-542.95-387.32-472.8-671.18-472.06
Cash per share
357.161.94K889.83303.67308.79
Book value per share
1.28K3.46K3.38K3.42K3.06K
Tangible book value per share
1.18K3.4K3.26K3.21K2.85K
Share holders equity per share
1.28K3.46K3.38K3.42K3.06K
Interest debt per share
1.3K795.93398.87395.61401.86
Market cap
215.3B596.79B1242.54B314.88B402.02B
Enterprise value
246.98B566.27B1251.52B319.5B406.9B
P/E ratio
-244.2-9.92-45.06-286.55-28.97
Price to sales ratio
6.5120.9531.555.685.8
POCF ratio
16.72-653.27-163.4548.8915.2
PFCF ratio
-14.55-54.99-74.13-12.89-23.37
P/B Ratio
6.166.1610.352.533.61
PTB ratio
6.166.1610.352.533.61
EV to sales
7.4719.8831.785.765.87
Enterprise value over EBITDA
19.33-42.92K-1.88K77.6724.12
EV to operating cash flow
19.18-619.86-164.6349.6115.38
EV to free cash flow
-16.69-52.18-74.67-13.08-23.65
Earnings yield
0-0.1-0.020-0.03
Free cash flow yield
-0.07-0.02-0.01-0.08-0.04
Debt to equity
10.210.110.110.12
Debt to assets
0.380.130.090.080.08
Net debt to EBITDA
2.482.31K-13.51.120.29
Current ratio
0.782.033.112.311.83
Interest coverage
30.19-2.79-8.63-4.345.44
Income quality
-14.610.020.28-5.86-1.91
Dividend Yield
00000
Payout ratio
00-0.0300
Sales general and administrative to revenue
00000
Research and developement to revenue
0.120.280.40.270.25
Intangibles to total assets
0.030.010.010.010.01
Capex to operating cash flow
-2.1510.881.2-4.79-1.65
Capex to revenue
-0.84-0.35-0.23-0.56-0.63
Capex to depreciation
-9.32-1.67-1.4-3.92-4.76
Stock based compensation to revenue
00.010.010.050
Graham number
966.1912.92K7.7K1.52K5.12K
ROIC
0.19-0.05-0.05-0.030.06
Return on tangible assets
-0.01-0.39-0.19-0.01-0.08
Graham Net
-1.56K168.42265.16-895.11-1.1K
Working capital
-5.99B36.21B36.44B34.34B21.61B
Tangible asset value
32.04B95.35B115.52B116.9B103.93B
Net current asset value
-36.32B12.33B20.55B3.12B-20.2B
Invested capital
10.210.110.110.12
Average receivables
04.3B5.62B5.69B9.8B
Average payables
0247.34M253.55M582.16M745.94M
Average inventory
08.46B12.01B16.39B15.68B
Days sales outstanding
24.5381.784542.8868.82
Days payables outstanding
7.543.254.489.46.32
Days of inventory on hand
195.45150.99214.63197.77132.66
Receivables turnover
14.884.468.118.515.3
Payables turnover
48.43112.4281.5538.8357.74
Inventory turnover
1.872.421.71.852.75
ROE
-0.03-0.62-0.23-0.01-0.12
Capex per share
-1.02K-354.71-258.36-848.1-1.2K

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
477.98394.97456.73313.68737.72
Net income per share
-87.57-2.9155.92-85.1-348.63
Operating cash flow per share
17.48-33.92292.13234.43233.09
Free cash flow per share
-237.18-130.87-357.8413.992.63
Cash per share
303.31188.46207.32234.59308.73
Book value per share
3.42K3.44K3.47K3.4K3.06K
Tangible book value per share
3.21K3.22K3.24K3.13K2.85K
Share holders equity per share
3.42K3.44K3.47K3.4K3.06K
Interest debt per share
377.78378.08382.17375.51375.82
Market cap
315.25B262.4B271.51B383.41B402.1B
Enterprise value
319.87B270.95B279.77B390.27B406.98B
P/E ratio
-24.7-618.933.31-30.9-7.91
Price to sales ratio
18.118.2316.3133.5414.95
POCF ratio
494.91-212.2925.544.8847.32
PFCF ratio
-36.47-55.01-20.82752.094.19K
P/B Ratio
2.532.092.153.093.61
PTB ratio
2.532.092.153.093.61
EV to sales
18.3618.8216.8134.1415.13
Enterprise value over EBITDA
-331.52161.2364.66-411.1134.46
EV to operating cash flow
502.16-219.226.2845.6847.9
EV to free cash flow
-37-56.81-21.45765.554.25K
Earnings yield
-0.0100.01-0.01-0.03
Free cash flow yield
-0.03-0.02-0.0500
Debt to equity
0.110.110.110.110.12
Debt to assets
0.080.080.080.080.08
Net debt to EBITDA
-4.795.081.91-7.230.41
Current ratio
2.311.741.651.431.83
Interest coverage
-13.09-1.865.21-10.720.25
Income quality
-0.211.665.22-2.75-0.67
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
0.330.360.360.40.06
Intangibles to total assets
0.010.020.010.020.01
Capex to operating cash flow
-14.572.86-2.22-0.94-0.99
Capex to revenue
-0.53-0.25-1.42-0.7-0.31
Capex to depreciation
-4.4-1.66-10.14-3.41-3.58
Stock based compensation to revenue
0.020.04-0.080.020
Graham number
2.59K474.442.09K2.55K4.9K
ROIC
-0.0200.02-0.020.08
Return on tangible assets
-0.0200.01-0.02-0.07
Graham Net
-894.05-474.65-573.63-718.24-1.1K
Working capital
34.34B17.16B15.07B10.36B21.61B
Tangible asset value
116.9B117.37B117.97B114.2B103.93B
Net current asset value
3.12B-1.69B-7.63B-12.22B-20.2B
Invested capital
0.110.110.110.110.12
Average receivables
5.84B9.45B12.8B9.15B9.08B
Average payables
676.76M629.1M376.33M435.94M578.49M
Average inventory
20.67B17.44B16.08B15.73B14.76B
Days sales outstanding
33.6777.3871.5439.9443.77
Days payables outstanding
6.275.033.95.784.25
Days of inventory on hand
131.95211.02170.09179.3389.28
Receivables turnover
2.671.161.262.252.06
Payables turnover
14.3517.923.0815.5721.16
Inventory turnover
0.680.430.530.51.01
ROE
-0.0300.02-0.03-0.11
Capex per share
-254.66-96.96-649.97-220.44-230.46

206650.KQ Frequently Asked Questions

What is EuBiologics Co., Ltd. stock symbol ?

EuBiologics Co., Ltd. is a KR stock and trading under the symbol 206650.KQ

What is EuBiologics Co., Ltd. stock quote today ?

EuBiologics Co., Ltd. stock price is $12120 today.

Is EuBiologics Co., Ltd. stock public?

Yes, EuBiologics Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks